Commission Decision No. 29-M-021/2019: In the Matter of the Proposed Acquisition by Natura Holdings, S.A. of Shares in Avon Products, Inc.   ABSTRACT: The Proposed Transaction involves the acquisition of Avon Products, Inc., a New York corporation (Avon), by Natura Cosméticos S.A. (Natura). A new holding company for the group, Natura Holding S.A (Natura &… continue reading ››

Commission Decision No. 28-M-VN-001/2019: In the Matter of the Proposed Conversion of Non-Voting Preferred Shares by Mitsubishi Corporation in Chiyoda Corporation   ABSTRACT: The proposed transaction involves the acquisition of control by Mitsubishi Corporation (Mitsubishi) over Chiyoda Corporation (Chiyoda) through the conversion of MC’s 175,000,000 A-class non-voting preferred shares to voting common shares in Chiyoda…. continue reading ››

Commission Decision No. 26-M-020/2019: In the Matter of Wingtech Technology, Co. Ltd. and Nexperia Holding B.V.’s Alleged Violation of the Compulsory Notification Requirements Under Section 2.1 of the PCC Rules on Merger Procedure   [PCC Case No. M-2019-006]    

Commission Decision No.25-M-022/2019 In the Matter of the Proposed Acquisition by Infineon Technologies AG of Shares in Cypress Semiconductor Corporation ABSTRACT: The proposed transaction involves a proposed merger between IFX Merger Sub Inc. (“IFX”), an indirectly wholly-owned subsidiary of Infineon Technologies AG (“Infineon”), and Cypress Semiconductor Corporation (“Cypress”), with Cypress as the surviving entity (the “Proposed Transaction”). Under… continue reading ››

Commission Decision No. 24-M-019/2019: In the Matter of the Proposed Acquisition by Metro Pacific Hospital Holdings, Inc. of Shares in Medical Doctors, Inc.   ABSTRACT: The transaction involves the proposed acquisition by Metro Pacific Hospital Holdings, Inc. (MPHHI) of shares in Medical Doctors, Inc. (MDI), which in turn owns and operates Makati Medical Center. Pursuant to… continue reading ››

PRESS RELEASE 2019-011 13 August 2019   PCC extends Grab’s commitment period as year-long monitoring lapses   The Philippine Competition Commission (PCC) is extending the effectivity period of the voluntary commitments undertaken by Grab Philippines, Inc. last year for the antitrust watchdog’s conditional clearance of its acquisition of Uber, in order to give way to… continue reading ››

    PRESS RELEASE 2019-010 5 August 2019 PCC, ERC ink partnership for power sector investigations  The Philippine Competition Commission (PCC) signed a Memorandum of Agreement (MOA) with the Energy Regulatory Commission (ERC) on Monday, completing the three-way partnership with the Department of Energy (DOE) in promoting competition and coordinating investigations in the energy sector…. continue reading ››

PRESS RELEASE 2019-009 1 August 2019   PCC streamlines merger rules for solicited PPP projects   The Philippine Competition Commission (PCC) has issued rules to streamline its merger review process for joint ventures formed for solicited public-private partnership (PPP) projects. In PCC Memorandum Circular No. 19-001 issued on July 2, the PCC detailed the procedure… continue reading ››

Commission Decision No. 20-M-005/2019: In the Matter of the Proposed Acquisition by GlaxoSmithKline Consumer Healthcare Holdings Ltd. of Pfizer Inc.’s Consumer Healthcare Business ABSTRACT The transaction involves the proposed acquisition by GlaxoSmithKline Consumer Health Holdings Ltd. (“GSK CH”) of Pfizer Inc.’s (“Pfizer”) Consumer Healthcare business (“Pfizer CH”). GSK CH, the acquiring entity, is an indirect… continue reading ››